Suanne White-Spunner, MD
Orthopaedic Surgery · Mobile, ALNPI 1235139668
Payments from drug & device makers
Across 138 payments — averaging $19.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Radius Health, Inc.$572
- Amgen$454
- Pacira Therapeutics, Inc.$312
- DJO, LLC$312
- Ferring Pharmaceuticals Inc.$284
- Endo Pharmaceuticals Inc.$150
- plus $564 from 17 others
What the payments were for
- Speaking & faculty fees$181%
- Food & beverage$2,63099%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Radius Health, Inc. | 26 | $572 |
| Amgen(2 entities) | 32 | $454 |
| Pacira Therapeutics, Inc. | 18 | $312 |
| DJO, LLC | 7 | $312 |
| Ferring Pharmaceuticals Inc. | 15 | $284 |
| Endo Pharmaceuticals Inc. | 9 | $150 |
| Sanofi-aventis U.S. LLC | 4 | $75 |
| Zyla Life Sciences, Inc. | 5 | $73 |
| Zimvie Inc. | 3 | $70 |
| Johnson & Johnson | 3 | $54 |
| Smith+Nephew | 2 | $38 |
| Skeletal Dynamics Inc | 2 | $35 |
| Bioventus LLC | 2 | $32 |
| AstraZeneca | 1 | $30 |
| Alvogen Inc | 1 | $24 |
| Avanos Medical | 1 | $23 |
| Orthofix Medical, Inc. | 1 | $21 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| Ultragenyx Pharmaceutical Inc. | 1 | $16 |
| Zimmer Biomet | 1 | $16 |
| Pfizer | 1 | $15 |
| Heraeus Medical, LLC. | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
How this compares
$2,648 in reported general payments places this provider in the 50th percentile of 319 orthopaedic surgery providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 260 | $9,463 |
| Tramadol Hcl | 69 | $714 |
| Gabapentin | 34 | $597 |
| Cyclobenzaprine Hcl | 29 | $305 |
| Tizanidine Hcl | 23 | $291 |
| Diclofenac Sodium | 17 | $279 |
| Celecoxib | 17 | $261 |
| Meloxicam | 59 | $194 |
| Tramadol Hcl-AcetaminophenTramadol Hcl/Acetaminophen | 12 | $166 |
| Alendronate Sodium | 26 | $135 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Mobile
- Matthew BarberMobile$190K
- Joseph ZarzourMobile$68K
- Russell GoodeMobile$50K
- Michael GranberryMobile$42K
- Jess MullensMobile$33K
- Clinton HowardMobile$24K
- Blake BowdenMobile$22K
- Jeffrey DugasBirmingham$11.7M
- Benton EmblomBirmingham$3.1M
- James SmithGadsden$2.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.